Stay updated on XmAb®20717 in Selected Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.

Latest updates to the XmAb®20717 in Selected Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe history now shows updated entries for changes to the study status, recruitment details, and locations. These entries capture when and what changed.SummaryDifference0.1%

 - Check9 days agoNo Change Detected
 - Check30 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference12%

 - Check37 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

 - Check52 days agoChange DetectedAdded revision: v3.0.2; removed previous revision: v3.0.1 and the 'Back to Top' element.SummaryDifference0.7%

 - Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.7%

 - Check66 days agoChange DetectedThe web page has undergone significant changes with the addition of a facility name and location, while several location-related terms and details have been removed.SummaryDifference21%

 
Stay in the know with updates to XmAb®20717 in Selected Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.